Lawrence Otto Klein Insider Profile
4 Followers
Lawrence Otto Klein, CBO & COO at Crispr Therapeutics AG, holds 927.31K shares in Oruka Therapeutics (Ticker: ORKA), holds 24.50K shares in Jasper Therapeutics (Ticker: JSPR), holds 26.80K shares in Crispr Therapeutics AG (Ticker: CRSP). Most recently, Lawrence Otto Klein Sold ― shares of Oruka Therapeutics on Mar 17, 2026 for an estimated value of $71.41K.
Lawrence Otto Klein has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lawrence Otto Klein holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Lawrence Otto Klein
Lawrence Otto Klein's Trading History
Crispr Therapeutics AG
Mar 14, 2022
CBO & COO
Uninformative Buy
279.42K
$1.39M
Dyne Therapeutics
Sep 23, 2020
Director
Uninformative Buy
―
$197.13K
Jasper Therapeutics
Oct 13, 2022
Director
Uninformative Buy
―
$17.32K
Oruka Therapeutics
Mar 17, 2026
CEO, Director
Informative Sell
71.41K
$57.50M
Jade Biosciences
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Lawrence Otto Klein's performance on stock
You May Also Like
Lawrence Otto Klein insider profile FAQ
What is the percentage of profitable transactions made by Lawrence Otto Klein?
The percentage of profitable transactions made by Lawrence Otto Klein is ―.
What is the average return per transaction made by Lawrence Otto Klein?
The average return per transaction made by Lawrence Otto Klein is ―.
What stocks does Lawrence Otto Klein hold?
Lawrence Otto Klein holds: CRSP, DYN, JSPR, ORKA, JBIO stocks.
What was Lawrence Otto Klein’s latest transaction?
Lawrence Otto Klein latest transaction was an Informative Sell of $71.41K.
What was Lawrence Otto Klein's most profitable transaction?
Lawrence Otto Klein’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Lawrence Otto Klein's role in Crispr Therapeutics AG?
Lawrence Otto Klein's role in Crispr Therapeutics AG is CBO & COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.